Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

T cell–depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin

Ann A. Jakubowski, Trudy N. Small, James W. Young, Nancy A. Kernan, Hugo Castro-Malaspina, Katherine C. Hsu, Miguel-Angel Perales, Nancy Collins, Christine Cisek, Michelle Chiu, Marcel R. M. van den Brink, Richard J. O'Reilly, Esperanza B. Papadopoulos

Blood (2007) 110 (13): 4552–4559.

https://doi.org/10.1182/blood-2007-06-093880

Published: 2007

Journal Articles

Graft Composition and Outcomes in Unrelated Donor Transplantation.

Nancy Collins, PhD, Adrian P. Gee, PhD, April Durrett, Fangyu Kan, MS, MA, Mei-Jie Zhang, PhD, Richard E. Champlin, MD, Dennis Confer, MD, Mary Eapen, MBBS, John E. Wagner, MD, Mary M. Horowitz, MD, MS, Daniel J. Weisdorf, MD

Blood (2007) 110 (11): 3065.

https://doi.org/10.1182/blood.V110.11.3065.3065

Published: 2007

Journal Articles

CD34+ Viability Is a Critical Determinant of the Engraftment Potential of Umbilical Cord Blood (UCB) in Double Unit Transplantation.

Andromachi Scaradavou, MD, Katherine Smith, PhD, Rebecca Hawke, Sinda Lee, Allison Schaible, Michelle Abboud, Nancy Collins, PhD, Nancy A. Kernan, MD, Marcel Van den Brink, MD, PhD, Juliet N. Barker, MBBS

Blood (2007) 110 (11): 2015.

https://doi.org/10.1182/blood.V110.11.2015.2015

Published: 2007

Journal Articles

Mobilization of Blood Stem Cells with G-CSF in Systemic Light-Chain Amyloidosis: Dominant Organ Involvement Significantly Affects Stem Cell Collection.

Raymond Comenzo, MD, Hani Hassoun, MD, Lilian Reich, MD, Nancy Collins, PhD, Andre Nuta, Xiaoshe Chen, PhD, Ping Zhou, MD. PhD, Bradly Clark, MD, Julie Teruya-Feldstein, MD, Martin Fleisher, PhD, David Wuest, MD, Stephen D. Nimer, MD

Blood (2006) 108 (11): 3087.

https://doi.org/10.1182/blood.V108.11.3087.3087

Published: 2006

Journal Articles

Fludarabine (Flu) Based Cytoreductive Regimen and T-Cell Depleted Grafts from Unrelated or Mismatched Related Donors for the Treatment of High Risk Patients with Fanconi Anemia (FA).

Farid Boulad, MD, Arleen D. Auerbach, PhD, Nancy A. Kernan, MD, Trudy N. Small, MD, Susan E. Prockop, MD, Sonali Chaudhury, MD, Joanne Castanza, RN, Anne Casson, RN, Catherine Copeland, RN, Heidi Abendroth, RN, Nancy Collins, PhD, Richard J. O’Reilly

Blood (2004) 104 (11): 2152.

https://doi.org/10.1182/blood.V104.11.2152.2152

Published: 2004

Journal Articles

A Phase II Trial of Busulfan, Melphalan, and Fludarabine followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants from HLA-Identical, or HLA-Non Identical Related or Unrelated Donors for the Treatment of Advanced Hematopoietic Malignancies.

Farid Boulad, MD, Ann Jakubowski, MD, Hugo Castro-Malaspina, MD, Katharine C. Hsu, MD, Nancy A. Kernan, MD, Esperanza B. Papadopoulos, MD, Miguel A. Perales, MD, Susan E. Prockop, MD, Trudy N. Small, MD, Marcel R.M. van den Brink, MD, James W. Young, MD, Michelle Ro, Nancy Collins, PhD, Richard J. O’Reilly, MD

Blood (2004) 104 (11): 1822.

https://doi.org/10.1182/blood.V104.11.1822.1822

Published: 2004

NARROW

T cell–depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin

Graft Composition and Outcomes in Unrelated Donor Transplantation.

CD34+ Viability Is a Critical Determinant of the Engraftment Potential of Umbilical Cord Blood (UCB) in Double Unit Transplantation.

Mobilization of Blood Stem Cells with G-CSF in Systemic Light-Chain Amyloidosis: Dominant Organ Involvement Significantly Affects Stem Cell Collection.

Fludarabine (Flu) Based Cytoreductive Regimen and T-Cell Depleted Grafts from Unrelated or Mismatched Related Donors for the Treatment of High Risk Patients with Fanconi Anemia (FA).

A Phase II Trial of Busulfan, Melphalan, and Fludarabine followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants from HLA-Identical, or HLA-Non Identical Related or Unrelated Donors for the Treatment of Advanced Hematopoietic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

T cell–depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin

Graft Composition and Outcomes in Unrelated Donor Transplantation.

CD34+ Viability Is a Critical Determinant of the Engraftment Potential of Umbilical Cord Blood (UCB) in Double Unit Transplantation.

Mobilization of Blood Stem Cells with G-CSF in Systemic Light-Chain Amyloidosis: Dominant Organ Involvement Significantly Affects Stem Cell Collection.

Fludarabine (Flu) Based Cytoreductive Regimen and T-Cell Depleted Grafts from Unrelated or Mismatched Related Donors for the Treatment of High Risk Patients with Fanconi Anemia (FA).

A Phase II Trial of Busulfan, Melphalan, and Fludarabine followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants from HLA-Identical, or HLA-Non Identical Related or Unrelated Donors for the Treatment of Advanced Hematopoietic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only